Major nuclear reactor manufacturer contributing industrial safety expertise to European research on plant life extension, severe accidents, and material ageing.
Framatome (formerly AREVA NP) is one of Europe's leading nuclear technology companies, providing reactor engineering, fuel assemblies, and safety services for nuclear power plants. Within H2020 research, they contribute deep industrial expertise in reactor pressure vessel integrity, material ageing under irradiation, and severe accident management. Their role is that of a major industry partner validating research findings against real reactor operating conditions and regulatory requirements. Based in Erlangen — Germany's nuclear engineering hub — they bridge the gap between academic nuclear safety research and actual plant operation.
Central theme across SOTERIA (radiation effects), TeaM Cables (cable ageing), ENTENTE (radiation damage database), ATLASplus (structural integrity for LTO), INCEFA-SCALE (environmental fatigue), and APAL (pressurised thermal shock for LTO).
ATLASplus focuses on structural integrity assessment tools, FRACTESUS on sub-sized specimen fracture testing, MEACTOS on environmentally assisted cracking, and APAL on reactor pressure vessel integrity under thermal shock.
MUSA addresses management and uncertainties of severe accidents including spent fuel pools, while AMHYCO targets hydrogen/CO combustion risk during severe accident progression.
PASTELS (their highest-funded project) investigates passive thermal-hydraulic safety systems through experimental studies and CFD benchmarking, and GEMINI Plus supports advanced reactor design with inherent safety features.
TeaM Cables (polymer cable ageing), MEACTOS (environmentally assisted cracking), INCEFA-SCALE (environmental assisted fatigue), and SOTERIA (radiation effects on materials) all address how reactor components degrade over decades of operation.
NARSIS develops new probabilistic safety assessment frameworks for natural external hazards, and APAL combines probabilistic and deterministic methods for integrity assessment.
In the early H2020 period (2015–2018), Framatome focused heavily on understanding material degradation mechanisms — radiation effects on reactor internals, cable polymer ageing, environmentally assisted cracking — essentially the science of why reactor components fail over time. From 2019 onward, their portfolio shifted toward accident scenarios and advanced safety demonstration: severe accident management (MUSA, AMHYCO), passive safety system validation (PASTELS), and benchmarking/database-building (ENTENTE, FRACTESUS). This signals a move from understanding degradation to proving that plants can operate safely beyond their original design life and demonstrating safety under extreme conditions.
Framatome is positioning itself at the intersection of life extension (LTO) and next-generation safety demonstration — exactly where European nuclear policy is heading as regulators decide which plants stay open and under what conditions.
Framatome participates exclusively as a consortium partner, never as coordinator — consistent with large industrial companies that contribute proprietary data, testing facilities, and regulatory expertise rather than managing research administration. With 118 unique partners across 26 countries, they do not concentrate on repeat partnerships but instead join diverse consortia wherever nuclear safety questions arise. This makes them a reliable, well-connected industry partner who brings real-world reactor experience to any consortium but expects the academic or research institute partner to lead.
Framatome has collaborated with 118 distinct partners spanning 26 countries, forming one of the broadest networks in European nuclear safety research. Their partnerships span nuclear regulators, national laboratories, universities, and fellow reactor vendors across both Western and Eastern Europe.
Framatome is one of very few commercial reactor manufacturers actively participating in EU nuclear safety research — most H2020 nuclear projects are dominated by research institutes and universities. They bring something almost no academic partner can: access to real reactor operating data, irradiated material specimens, and direct knowledge of how safety assessments translate into regulatory license extensions. For any consortium working on reactor life extension, severe accidents, or advanced safety systems, Framatome provides the industrial validation that turns research into regulatory evidence.
